International Journal of Oncology

microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review)
pp. 1189-1195(7)
Authors: Wong, May Y.W.; Yu, Yan; Walsh, William R.; Yang, Jia-Lin

Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition (Review)
pp. 1197-1217(21)
Authors: Al Saleh, Sanaa; Sharaf, Leyla H.; Luqmani, Yunus A.

Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis
pp. 1219-1226(8)
Authors: Katayama, Akihiro; Takahara, Miki; Kishibe, Kan; Nagato, Toshihiro; Kunibe, Isamu; Katada, Akihiro; Hayashi, Tatsuya; Harabuchi, Yasuaki

Alteration of p53-binding protein 1 expression as a risk factor for local recurrence in patients undergoing resection for extrahepatic cholangiocarcinoma
pp. 1227-1236(10)
Authors: Wakai, Toshifumi; Shirai, Yoshio; Sakata, Jun; Korita, Pavel V.; Matsuda, Yasunobu; Takamura, Masaaki; Ohashi, Riuko; Nagahashi, Masayuki; Ajioka, Yoichi; Hatakeyama, Katsuyoshi

Synergistic antitumor effect of interferon-ß with gemcitabine in interferon-α-non-responsive pancreatic cancer cells
pp. 1237-1243(7)
Authors: Tomimaru; Eguchi; Wada; Tomokuni; Kobayashi; Marubashi; Takeda; Tanemura; Umeshita; Mori; Doki; Nagano

Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation
pp. 1245-1252(8)
Authors: Ashizawa, Tadashi; Miyata, Haruo; Ishii, Hidee; Oshita, Chie; Matsuno, Kenji; Masuda, Yoshiaki; Furuya, Toshio; Okawara, Tadashi; Otsuka, Masami; Ogo, Naohisa; Asai, Akira; Akiyama, Yasuto

Morphological and cytoskeletal alterations of nervous system tumor cells with different culturing methods
pp. 1253-1258(6)
Authors: Matsuda; Kawamoto; Teduka; Peng; Yamamoto; Ishiwata; Naito

Auto-stimulatory action of secreted caveolin-1 on the proliferation of Ewing's sarcoma cells
pp. 1259-1265(7)
Authors: Sengupta, Aniruddha; Mateo-Lozano, Silvia; Tirado, Oscar M.; Notario, Vicente

PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells
pp. 1267-1277(11)
Authors: Catchpole; Spencer-Dene; Hall; Santangelo; Rosewell; Guenatri; Beatson; Scibetta; Burchell; Taylor-Papadimitriou

CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion
pp. 1279-1285(7)
Authors: Johnson-Holiday, Crystal; Singh, Rajesh; Johnson, Erica; Singh, Shailesh; Stockard, Cecil R.; Grizzle, William E.; Lillard, James W.

The heterogeneity of meningioma revealed by multiparameter analysis: infiltrative and non-infiltrative clinical phenotypes
pp. 1287-1297(11)
Authors: Gay; Lages; Ramus; Guttin; El Atifi; Dupré; Bouamrani; Salon; Ratel; Wion; Berger; Issartel

Potent anti-tumor killing activity of the multifunctional Treg cell line HOZOT against human tumors with diverse origins
pp. 1299-1306(8)
Authors: Inoue, Toshiya; Tashiro, Yuichi; Takeuchi, Makoto; Otani, Takeshi; TsujiTakayama, Kazue; Okochi, Ayumi; Mukae, Yuriko; Koreishi, Mayuko; Yamasaki, Fumiyuki; Kumon, Hiromi; Nakamura, Shuji; Kibata, Masayoshi; Kondo, Eisaku

SV40 and p53 as team players in childhood lymphoproliferative disorders
pp. 1307-1317(11)
Authors: Heinsohn, Susanne; Scholz, Roswitha; Kabisch, Hartmut

Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin
pp. 1319-1327(9)
Authors: Zhao, Sufen; Ye, Gang; Fu, Guodong; Cheng, Jian-Xin; Yang, Burton B.; Peng, Chun

Antitumor activity of nifurtimox is enhanced with tetrathiomolybdate in medulloblastoma
pp. 1329-1341(13)
Authors: Koto, Karen S.; Lescault, Pamela; Brard, Laurent; Kim, Kyukwang; Singh, Rakesh K.; Bond, Jeff; Illenye, Sharon; Slavik, Marni A.; Ashikaga, Takamaru; Saulnier Sholler, Giselle L.

Selective enrichment of hypericin in malignant glioma: Pioneering in vivo results
pp. 1343-1348(6)
Authors: Noell; Mayer; Strauss; Tatagiba; Ritz

Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium
pp. 1349-1355(7)
Authors: Liu, Tiancheng; Jabbes, Mohamed; Nedrow-Byers, Jessie R.; Wu, Lisa Y.; Bryan, Jeffrey N.; Berkman, Clifford E.

The novel synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells
pp. 1357-1364(8)
Authors: Huang; Yang; Tsai; Chen; Hsu; Lin; Chou; Chinag; Lee; Huang; Kuo

Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells
pp. 1365-1373(9)
Authors: Vidal; de Araujo; Cruz; Tanaka; Viola; Morgado-Díaz

Roles of cyclin-dependent kinase 8 and β-catenin in the oncogenesis and progression of gastric adenocarcinoma
pp. 1375-1383(9)
Authors: Kim; Han; Lim

Microarray-based analysis: Identification of hypoxia-regulated microRNAs in retinoblastoma cells
pp. 1385-1393(9)
Authors: Xu, Xiaofang; Jia, Renbing; Zhou, Yixiong; Song, Xin; Wang, Jing; Qian, Guanxiang; Ge, Shengfang; Fan, Xianqun

Regulation of cancer cell proliferation by caveolin-2 down-regulation and re-expression
pp. 1395-1402(8)
Authors: Lee, Sangho; Kwon, Hayeong; Jeong, Kyuho; Pak, Yunbae

(-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression
pp. 1403-1408(6)
Authors: Onoda, Chihiro; Kuribayashi, Kageaki; Nirasawa, Shinya; Tsuji, Naoki; Tanaka, Maki; Kobayashi, Daisuke; Watanabe, Naoki

Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro
pp. 1409-1419(11)
Authors: Kitoh; Saio; Gotoh; Umemura; Nonaka; Bai; Vizkeleti; Torocsik; Balazs; Adany; Takami

The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidine
pp. 1421-1425(5)
Authors: Liu, H. B.; Mayes, P. A.; Perlmutter, P.; McKendrick, J. J.; Dear, A. E.

Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells
pp. 1427-1436(10)
Authors: Meli; Tolomeo; Grifantini; Mai; Cappellacci; Petrelli; Rotili; Ferro; Saiko; Szekeres; Dusonchet

MicroRNA miR-125b is a prognostic marker in human colorectal cancer
pp. 1437-1443(7)
Authors: Nishida, Naohiro; Yokobori, Takehiko; Mimori, Koshi; Sudo, Tomoya; Tanaka, Fumiaki; Shibata, Kohei; Ishii, Hideshi; Doki, Yuichiro; Kuwano, Hiroyuki; Mori, Masaki

p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancer
pp. 1445-1452(8)
Authors: Yang, Sherry X.; Steinberg, Seth M.; Nguyen, Dat; Swain, Sandra M.

Temozolomide-induced modification of the CXC chemokine network in experimental gliomas
pp. 1453-1464(12)
Authors: Bruyère; Mijatovic; Lonez; Spiegl-Kreinecker; Berger; Kast; Ruysschaert; Kiss; Lefranc

Pooled analysis of case-control studies on malignant brain tumours and the use of mobile and cordless phones including living and deceased subjects
pp. 1465-1474(10)
Authors: Hardell, Lennart; Carlberg, Michael; Hansson Mild, Kjell

Effect of PP2A on p34SEI-1 expression in response to ionizing radiation in MCF-7 human breast cancer cells
pp. 1475-1482(8)
Authors: Jung; Jeong; Shin; Lee